statistiche ricercatore

statistiche per BIONDI, ANDREA

Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 33906
EU - Europa 6784
AS - Asia 3120
Continente sconosciuto - Info sul continente non disponibili 49
SA - Sud America 29
AF - Africa 21
OC - Oceania 11
Totale 43920
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33397
CN - Cina 2305
IT - Italia 1769
UA - Ucraina 1533
SE - Svezia 1051
GB - Regno Unito 653
CA - Canada 501
VN - Vietnam 369
DE - Germania 353
FI - Finlandia 323
FR - Francia 250
RU - Federazione Russa 247
AT - Austria 231
TR - Turchia 215
DK - Danimarca 194
IN - India 121
EU - Europa 37
IR - Iran 37
JP - Giappone 30
NL - Olanda 29
BG - Bulgaria 26
RO - Romania 23
CH - Svizzera 17
BR - Brasile 14
PL - Polonia 14
ES - Italia 13
KR - Corea 13
GR - Grecia 12
AU - Australia 11
BE - Belgio 10
CL - Cile 9
A2 - ???statistics.table.value.countryCode.A2??? 7
ID - Indonesia 7
IE - Irlanda 7
SC - Seychelles 7
GT - Guatemala 5
MU - Mauritius 5
NO - Norvegia 5
A1 - ???statistics.table.value.countryCode.A1??? 4
AL - Albania 4
CZ - Repubblica Ceca 4
IL - Israele 4
PT - Portogallo 4
RE - Reunion 4
TW - Taiwan 4
AR - Argentina 3
MX - Messico 3
PH - Filippine 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
EG - Egitto 2
HK - Hong Kong 2
SI - Slovenia 2
ZA - Sudafrica 2
AP - ???statistics.table.value.countryCode.AP??? 1
BY - Bielorussia 1
CO - Colombia 1
HU - Ungheria 1
IQ - Iraq 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
PE - Perù 1
TH - Thailandia 1
UZ - Uzbekistan 1
VA - Santa Sede (Città del Vaticano) 1
VE - Venezuela 1
Totale 43920
Salva come PNG Salva come JPEG
Città #
Ann Arbor 8885
Woodbridge 4512
Fairfield 4208
Houston 3473
Wilmington 2415
Jacksonville 1836
Seattle 1613
Ashburn 1612
Cambridge 1454
Dearborn 1266
Milan 588
Nanjing 514
Beijing 328
Lachine 309
San Diego 268
Vienna 224
Dong Ket 195
Nanchang 149
Lissone 140
Guangzhou 131
Hebei 128
Shenyang 115
Changsha 103
Tianjin 100
Jinan 90
Fremont 86
Norwalk 85
Falls Church 82
Ottawa 81
Jiaxing 76
Hangzhou 73
Fuzhou 66
Mountain View 59
Zhengzhou 57
Rome 56
Ningbo 55
Kocaeli 53
Toronto 49
Kunming 48
Redmond 44
Edmonton 42
Hefei 39
Taizhou 33
Grafing 29
University Park 28
Auburn Hills 26
Besana In Brianza 23
Shanghai 23
Chengdu 21
Sacramento 21
Contursi 20
Nürnberg 19
Plovdiv 18
Padova 17
Perugia 17
Andover 16
Leawood 15
Detroit 14
Haikou 14
Kiev 14
Zanjan 14
Göttingen 13
Los Angeles 13
Brugherio 12
Changchun 12
Bologna 11
Munich 11
Wuhan 11
Brindisi 10
Como 10
Lanzhou 10
Napoli 10
San Mateo 10
Torino 10
Daejeon 9
Duncan 9
Florence 9
Merate 9
Fort Worth 8
Athens 7
Brooklyn 7
Hanoi 7
Kraków 7
San Giuliano 7
Ardea 6
Bari 6
Chicago 6
Clearwater 6
Monmouth Junction 6
Mumbai 6
Taiyuan 6
Tokyo 6
Trento 6
Turin 6
Ypsilanti 6
Baltimore 5
Bergamo 5
Busto Arsizio 5
Casorate Primo 5
Chongqing 5
Totale 36402
Salva come PNG Salva come JPEG
Nome #
miRNA-regulated gene expression differs in celiac disease patients according to the age of presentation 345
Intraperitoneal adoptive transfer of mesenchymal stem cells enhances recovery from acid aspiration acute lung injury in mice 323
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 269
Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action 266
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 265
NIPBL: a new player in myeloid cells differentiation 258
Hepatic granulomatous lesions caused by systemic bartonella vinsonii subsp. arupensis infection in a child 257
Acute myeloid leukaemia niche regulates response to L-asparaginase 251
Enzymatic replacement therapy for Hunter disease: Up to 9 years experience with 17 patients 249
First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia 246
Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection 236
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies 230
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960–1999 and registered in the Italian Off-Therapy Registry 229
Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group 226
Phenotypical and Functional Characterization of Mesenchymal Stem Cells Derived From Patients Affected by Schwachman-Diamond Syndrome 223
Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation 218
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells 217
Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories 214
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation 212
Prevalence of Immunological Defects in a Cohort of 97 Rubinstein–Taybi Syndrome Patients 210
Diagnosis and monitoring of PML-RARA-positive acute promyelocytic leukemia by qualitative RT-PCR 209
Prenatal Origin of Pediatric Leukemia: Lessons From Hematopoietic Development 206
Globalization of pediatric research: Pharmacological RCTs in Latin America 202
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 201
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring 201
Moral distress in nurses in oncology and haematology units 201
Hodgkin lymphoma in a patient with mosaic trisomy 18: First clinical observation 193
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 190
Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+ Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy 189
Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy 185
AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia 184
Activin A contributes to the definition of a pro-oncogenic bone marrow microenvironment in t(12;21) preleukemia 184
Mesenchymal stromal cells from Shwachman-Diamond syndrome patients fail to recreate a bone marrow niche in vivo and exhibit impaired angiogenesis 183
How I treat infant leukemia 181
Fludarabine as a cost-effective adjuvant to enhance engraftment of human normal and malignant hematopoiesis in immunodeficient mice 179
A new case report of severe mucopolysaccharidosis type VII: Diagnosis, treatment with haematopoietic cell transplantation and prenatal diagnosis in a second pregnancy 11 Medical and Health Sciences 1114 Paediatrics and Reproductive Medicine 178
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 175
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 174
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study 174
Antileukemic efficacy of BET inhibitor in a preclinical mouse model of MLL-AF4 + infant ALL 172
Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. 168
Human umbilical cord blood-borne fibroblasts contain marrow niche precursors that form a bone/marrow organoid in vivo 167
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 166
T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy 166
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition 164
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting 163
Acute myeloid leukemia shapes the bone marrow stromal niche in vivo 162
A novel EP300 mutation associated with Rubinstein-Taybi syndrome type 2 presenting as combined immunodeficiency 161
From Adjustment to Thriving: Exploring Well-Being in Young Adult Survivors of Childhood Cancer and Their Siblings 160
Reduced-Intensity delayed intensification in standard-Risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: Results of an international randomized trial (AIEOP-BFM ALL 2000) 157
A simple RNA target capture NGS strategy for fusion genes assessment in the diagnostics of pediatric B-cell acute lymphoblastic leukemia 157
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia 156
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche 156
Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors 155
Early diagnosis of PI3Kδ syndrome in a 2 years old girl with recurrent otitis and enlarged spleen 154
Immunotherapy of acute leukemia by chimeric antigen receptormodified lymphocytes using an improved Sleeping Beauty transposon platform 153
Oral nutritional supplementation in children treated for cancer in low- and middle-income countries is feasible and effective: The experience of the children's hospital manuel de jesus rivera "la mascota" in Nicaragua 153
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 153
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 152
Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study 152
Mesenchymal stromal cell-derived PTX3 promotes wound healing via fibrin remodeling 149
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection 148
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms 144
Interleukin-17-Producing T-Helper Cells as New Potential Player Mediating Graft-Versus-Host Disease in Patients Undergoing Allogeneic Stem-Cell Transplantation 143
IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia 143
Human aplastic anaemia-derived mesenchymal stromal cells form functional haematopoietic stem cell niche in vivo 142
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 142
Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype 142
Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy 141
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 139
Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. 139
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia 138
Development of a quantitative-PCR method for specific FLT3/ITD monitoring in acute myeloid leukemia 138
CyclinD1 Down-Regulation and Increased Apoptosis Are Common Features of Cohesinopathies 137
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 137
WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia? 136
Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary Therapy 136
Location First: Targeting Acute Myeloid Leukemia Within Its Niche 136
Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol 135
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia 135
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia 135
GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease 135
Chimeric T-cell receptors: new challenges for targeted immunotherapy in hematologic malignancies 135
Platelet-lysate-Expanded Mesenchymal Stromal Cells as a Salvage Therapy for Severe Resistant Graft-versus-Host Disease in a Pediatric Population 133
Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T-cell perturbations 133
Modeling Cornelia de Lange syndrome in vitro and in vivo reveals a role for cohesin complex in neuronal survival and differentiation 132
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: High white blood cell count at diagnosis is the strongest prognostic factor 132
PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells 132
Highly sensitive mutations detection in BCR-ABL positive leukemia prior and during imatinib treatment 132
Cytoskeletal Regulatory Gene Expression and Migratory Properties of B Cell Progenitors are Affected by the ETV6-RUNX1 Rearrangement 132
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study 132
Characterization of CD20-transduced T lymphocytes as an alternative suicide gene therapy approach for the treatment of graft-versus-host disease 130
Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia 130
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency 129
Gemtuzumab ozogamicin (Mylotarg) has therapeutic activity against CD33(+) acute lymphoblastic leukaemias in vitro and in vivo 129
Efficient detection of leukemia-related fusion transcripts by multiplex PCR applied on a microelectronic platform 129
Development of an algorithm for the management of cervical lymphadenopathy in children: Consensus of the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Society of Pediatric Infectious Diseases and the Italian Society of Pediatric Otorhinolaryngology 128
Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations 128
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati 128
Mesenchymal stromal cell-secreted chemerin is a novel immunomodulatory molecule driving the migration of ChemR23-expressing cells 127
Totale 17301
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46469
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46469
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2016/2017844 0000 00 00 000844
2017/20186977 110624962473227 10221 62204 59619868
2018/20195194 911456472 107505 239188 23066313761514
2019/202012994 15008759191179 12761587 1709890 1216711799333
2020/202111688 57177212431140 8801045 11031072 91511997251023
2021/20226904 526839951528 425513 350389 568539592684
Totale 46469
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie-Privacy
Logo CINECA  Copyright © 2022